Long Non-coding RNAs As the Critical Factors During Tumor Progressions Among Iranian Population: an Overview

Overview

Journal Cell Biosci

Publisher Biomed Central

Specialty Biology

Date 2020 Jan 21

PMID 31956395

Citations 19

Authors

Zahra Rahmani

Majid Mojarrad

Meysam Moghbeli

Affiliations

Soon will be listed here.

Abstract

Background: Cancer is associated with various genetic and environmental risk factors. Beside the mutations or aberrant expression of protein-coding genes, the genetic deregulation of non-coding RNAs has also an important role during tumor progression and metastasis. Long non-coding RNAs (lncRNAs) are a class of ncRNAs larger than 200 nucleotides that may function as tumor-suppressor or oncogene.

Main Body: There is a raising trend of cancer incidence among Iranian population during the last decades. Therefore, it is required to prepare a general population specific panel of genetic markers for the early detection of cancer in this population. The tissue-specific expression characteristics and high stability in body fluids highlight the lncRNAs as efficient diagnostic and prognostic noninvasive biomarkers in cancer. In present review we summarized all of the lncRNAs which have been reported until now in different tumors among Iranian patients.

Conclusions: This review paves the way of introducing a population based noninvasive diagnostic panel of lncRNAs for the early detection of tumor cells among Iranian population.

Citing Articles

HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives.

Nazari M, Babakhanzadeh E, Mollazadeh A, Ahmadzade M, Mohammadi Soleimani E, Hajimaqsoudi E Cancer Cell Int. 2024; 24(1):415.

PMID: 39702144 PMC: 11660992. DOI: 10.1186/s12935-024-03612-x.

Role of microRNA-494 in tumor progression.

Maharati A, Akhlaghipour I, Taghehchian N, Yazdi Z, Moghbeli M Am J Transl Res. 2023; 15(11):6342-6361.

PMID: 38074823 PMC: 10703645.

PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression.

Taghehchian N, Maharati A, Akhlaghipour I, Zangouei A, Moghbeli M Cancer Cell Int. 2023; 23(1):233.

PMID: 37807067 PMC: 10561470. DOI: 10.1186/s12935-023-03086-3.

MicroRNAs as the critical regulators of Forkhead box protein family during gynecological and breast tumor progression and metastasis.

Taghehchian N, Lotfi M, Zangouei A, Akhlaghipour I, Moghbeli M Eur J Med Res. 2023; 28(1):330.

PMID: 37689738 PMC: 10492305. DOI: 10.1186/s40001-023-01329-7.

Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression.

Maharati A, Moghbeli M J Transl Med. 2023; 21(1):556.

PMID: 37596669 PMC: 10439650. DOI: 10.1186/s12967-023-04434-7.

References

Almutairi M, Reddy Parine N, Shaik J, Aldhaian S, Azzam N, Aljebreen A . Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population. PLoS One. 2019; 14(9):e0220931. PMC: 6728072. DOI: 10.1371/journal.pone.0220931. View

Mizrahi A, Czerniak A, Levy T, Amiur S, Gallula J, Matouk I . Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med. 2009; 7:69. PMC: 2734756. DOI: 10.1186/1479-5876-7-69. View

Emadi-Andani E, Nikpour P, Emadi-Baygi M, Bidmeshkipour A . Association of HOTAIR expression in gastric carcinoma with invasion and distant metastasis. Adv Biomed Res. 2014; 3:135. PMC: 4063112. DOI: 10.4103/2277-9175.133278. View

Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y . LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis. 2014; 5:e1287. PMC: 4611722. DOI: 10.1038/cddis.2014.249. View

Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N . Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016; 7:13616. PMC: 5150648. DOI: 10.1038/ncomms13616. View

Yuan W, Li X, Liu L, Wei C, Sun D, Peng S . Comprehensive analysis of lncRNA-associated ceRNA network in colorectal cancer. Biochem Biophys Res Commun. 2018; 508(2):374-379. DOI: 10.1016/j.bbrc.2018.11.151. View

Arshi A, Sharifi F, Khorramian Ghahfarokhi M, Faghih Z, Doosti A, Ostovari S . Expression Analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in Breast Cancer Tissues from Young Women and Women over 45 Years of Age. Mol Ther Nucleic Acids. 2018; 12:751-757. PMC: 6108071. DOI: 10.1016/j.omtn.2018.07.014. View

Huang X, Xia Y, He G, Zheng L, Cai Y, Yin Y . MALAT1 promotes angiogenesis of breast cancer. Oncol Rep. 2018; 40(5):2683-2689. DOI: 10.3892/or.2018.6705. View

Jones P, Baylin S . The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3(6):415-28. DOI: 10.1038/nrg816. View

10.

Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S . Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016; 4(9):e609-16. DOI: 10.1016/S2214-109X(16)30143-7. View

11.

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

12.

Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J . Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012; 279(17):3159-65. DOI: 10.1111/j.1742-4658.2012.08694.x. View

13.

Li L, Guo G, Zhang H, Zhou B, Bai L, Chen H . Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study. BMC Med Genet. 2018; 19(1):136. PMC: 6090654. DOI: 10.1186/s12881-018-0573-1. View

14.

Gao S, Wang P, Hua Y, Xi H, Meng Z, Liu T . ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget. 2015; 7(2):1608-18. PMC: 4811484. DOI: 10.18632/oncotarget.6450. View

15.

Wang L, Niu Y, He G, Wang J . Down-regulation of lncRNA GAS5 attenuates neuronal cell injury through regulating miR-9/FOXO3 axis in cerebral ischemic stroke. RSC Adv. 2022; 9(28):16158-16166. PMC: 9064354. DOI: 10.1039/c9ra01544b. View

16.

Qu F, Cao P . Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2. Exp Cell Res. 2018; 369(2):187-196. DOI: 10.1016/j.yexcr.2018.05.017. View

17.

Wang Y, Jiang X, Feng Z, Li X, Zhang W . Long noncoding RNA PCAT-1 accelerates the metastasis of pancreatic cancer by repressing RBM5. Eur Rev Med Pharmacol Sci. 2019; 23(17):7350-7355. DOI: 10.26355/eurrev_201909_18841. View

18.

Farhangian P, Jahandoost S, Mowla S, Khalili M . Differential expression of long non-coding RNA SOX2OT in gastric adenocarcinoma. Cancer Biomark. 2018; 23(2):221-225. DOI: 10.3233/CBM-181325. View

19.

Jiang F, Zhou X, Huang J . Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy. PLoS One. 2016; 11(4):e0152767. PMC: 4833345. DOI: 10.1371/journal.pone.0152767. View

20.

Beltran M, Puig I, Pena C, Garcia J, Alvarez A, Pena R . A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev. 2008; 22(6):756-69. PMC: 2275429. DOI: 10.1101/gad.455708. View